784737002: Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing sigma-1 receptor agonist (product)\Product containing dextromethorphan (medicinal product)\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine (medicinal product)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing sigma-1 receptor agonist (product)\Product containing dextromethorphan (medicinal product)\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing sigma-1 receptor agonist (product)\Product containing dextromethorphan (medicinal product)\Product containing dextromethorphan in oral dose form (medicinal product form)\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing N-methyl-D-aspartate receptor antagonist product receptor antagonist (product)\Product containing dextromethorphan (medicinal product)\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine (medicinal product)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing N-methyl-D-aspartate receptor antagonist product receptor antagonist (product)\Product containing dextromethorphan (medicinal product)\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing N-methyl-D-aspartate receptor antagonist product receptor antagonist (product)\Product containing dextromethorphan (medicinal product)\Product containing dextromethorphan in oral dose form (medicinal product form)\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing histamine receptor antagonist (product)\Product containing propylamine derivative and histamine receptor antagonist (product)\Product containing brompheniramine (medicinal product)\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine (medicinal product)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing histamine receptor antagonist (product)\Product containing propylamine derivative and histamine receptor antagonist (product)\Product containing brompheniramine (medicinal product)\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing histamine receptor antagonist (product)\Product containing propylamine derivative and histamine receptor antagonist (product)\Product containing brompheniramine (medicinal product)\Brompheniramine-containing product in oral dose form\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)

\Medicinal product categorized by structure\Ether structure-containing product\Product containing dextromethorphan (medicinal product)\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine (medicinal product)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Medicinal product categorized by structure\Ether structure-containing product\Product containing dextromethorphan (medicinal product)\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Medicinal product categorized by structure\Ether structure-containing product\Product containing dextromethorphan (medicinal product)\Product containing dextromethorphan in oral dose form (medicinal product form)\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing propylamine (product)\Product containing propylamine derivative and histamine receptor antagonist (product)\Product containing brompheniramine (medicinal product)\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine (medicinal product)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing propylamine (product)\Product containing propylamine derivative and histamine receptor antagonist (product)\Product containing brompheniramine (medicinal product)\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing propylamine (product)\Product containing propylamine derivative and histamine receptor antagonist (product)\Product containing brompheniramine (medicinal product)\Brompheniramine-containing product in oral dose form\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing phenylpropanolamine (medicinal product)\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine (medicinal product)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing phenylpropanolamine (medicinal product)\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing phenylpropanolamine (medicinal product)\Phenylpropanolamine-containing product in oral dose form\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Medicinal product categorized by structure\Product containing alcohol (product)\Product containing phenylpropanolamine (medicinal product)\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine (medicinal product)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Medicinal product categorized by structure\Product containing alcohol (product)\Product containing phenylpropanolamine (medicinal product)\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Medicinal product categorized by structure\Product containing alcohol (product)\Product containing phenylpropanolamine (medicinal product)\Phenylpropanolamine-containing product in oral dose form\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)

\Medicinal product categorised by therapeutic role\Antitussive agent\Product containing dextromethorphan (medicinal product)\...

\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine (medicinal product)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)

\Product containing dextromethorphan in oral dose form (medicinal product form)\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)

\Product manufactured as oral dose form (product)\Product containing dextromethorphan in oral dose form (medicinal product form)\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Product manufactured as oral dose form (product)\Phenylpropanolamine-containing product in oral dose form\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Product manufactured as oral dose form (product)\Brompheniramine-containing product in oral dose form\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)

\Product containing autonomic agent (product)\Product containing sympathomimetic (product)\Product containing phenylpropanolamine (medicinal product)\...

\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine (medicinal product)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)

\Phenylpropanolamine-containing product in oral dose form\Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3765363017 Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3765364011 Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

4528181000052112 bromfeniraminmaleat 400 mikrogram/milliliter, dextrometorfanhydrobromid 2 milligram/milliliter och fenylpropanolaminhydroklorid 2,5 milligram/milliliter, oral lösning sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	Has manufactured dose form	Oral solution	true	Inferred relationship	Some
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	1 (qualifier value)	false	Inferred relationship	Some	3
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	3
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	2
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	1
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	1 (qualifier value)	false	Inferred relationship	Some	2
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	2
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	1 (qualifier value)	false	Inferred relationship	Some	1
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	räkning av bas i aktiv ingrediens	3 (qualifier value)	false	Inferred relationship	Some
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	Is a	Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)	true	Inferred relationship	Some
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	har täljarvärde för koncentrationsstyrka	2 (qualifier value)	false	Inferred relationship	Some	2
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	3
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	har täljarvärde för koncentrationsstyrka	2.5 (qualifier value)	false	Inferred relationship	Some	3
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	Has basis of strength substance (attribute)	Phenylpropanolamine hydrochloride	true	Inferred relationship	Some	3
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	Has precise active ingredient	Dextromethorphan hydrobromide (substance)	true	Inferred relationship	Some	2
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	Has basis of strength substance (attribute)	Dextromethorphan hydrobromide (substance)	true	Inferred relationship	Some	2
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength numerator unit	mcg	true	Inferred relationship	Some	1
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	Has precise active ingredient	Brompheniramine maleate	true	Inferred relationship	Some	1
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	Has precise active ingredient	Phenylpropanolamine hydrochloride	true	Inferred relationship	Some	3
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	Has basis of strength substance (attribute)	Brompheniramine maleate	true	Inferred relationship	Some	1
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	har täljarvärde för koncentrationsstyrka	400 (qualifier value)	false	Inferred relationship	Some	1
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	Plays role	Antitussive therapeutic role (role)	true	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3765363017	Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3765364011	Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
4528181000052112	bromfeniraminmaleat 400 mikrogram/milliliter, dextrometorfanhydrobromid 2 milligram/milliliter och fenylpropanolaminhydroklorid 2,5 milligram/milliliter, oral lösning	sv	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Sweden NRC maintained module (core metadata concept)